## SYK: Stryker Corporation - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 1.47 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-3.4% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($351.89)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Van Hulzen Asset Management LLC Grows Stake in Stryker Corporation $SYK**
- Source: MarketBeat | 20251203T140948 | Somewhat-Bullish | Relevance: 100%
- Van Hulzen Asset Management LLC significantly increased its stake in Stryker Corporation by 1,159.4% in Q2, bringing its total holdings to 15,642 shares valued at approximately $6.19 million. This move comes as institutional investors collectively own about 77.1% of Stryker, despite recent insider sales totaling $185.4 million. Stryker reported strong Q2 earnings, beating estimates with $3.19 EPS and $6.06 billion in revenue, and maintains a "Moderate Buy" consensus rating with a target price of $433.78.

**2. Railway Pension Investments Ltd Cuts Position in Stryker Corporation $SYK**
- Source: MarketBeat | 20251201T133834 | Somewhat-Bullish | Relevance: 100%
- Railway Pension Investments Ltd reduced its stake in Stryker Corporation by 4.7% in Q2, selling 1,900 shares and ending with 38,600 shares valued at $15.27 million. Institutional ownership of Stryker stands at 77.09%, while insiders sold a total of 522,118 shares valued at approximately $185.38 million in the last quarter. Analysts maintain a "Moderate Buy" rating with an average price target of $434.37, following strong Q3 results and positive FY2025 guidance.

**3. Boston Family Office LLC Purchases 1,882 Shares of Stryker Corporation $SYK**
- Source: MarketBeat | 20251201T083128 | Somewhat-Bullish | Relevance: 100%
- Boston Family Office LLC increased its stake in Stryker Corporation by 2.9% in Q2, acquiring 1,882 shares, bringing its total to 66,391 shares valued at $26,266,000. Other major institutions like Vanguard, Price T. Rowe, Geode, and Norges Bank also increased their holdings, while corporate insiders sold a significant number of shares. Stryker recently exceeded quarterly EPS estimates with strong revenue growth and provided optimistic FY2025 EPS guidance, leading analysts to rate the stock as a "Moderate Buy."

**4. Groupe la Francaise Purchases 46,259 Shares of Stryker Corporation $SYK**
- Source: MarketBeat | 20251203T095435 | Somewhat-Bullish | Relevance: 98%
- Groupe la Francaise significantly increased its stake in Stryker Corporation (NYSE:SYK) by 462.3% during the second quarter, acquiring an additional 46,259 shares, bringing its total holdings to 56,266 shares valued at $22.18 million. This move is part of a broader trend of institutional investment in Stryker, with other major investors like Vanguard Group Inc., Price T Rowe Associates Inc. MD, Geode Capital Management LLC, Norges Bank, and Goldman Sachs Group Inc. also increasing their positions. The article also provides recent financial performance, analyst ratings, and insider trading activity for Stryker.

**5. Northwestern Mutual Wealth Management Co. Has $21.53 Million Stake in Stryker Corporation $SYK**
- Source: MarketBeat | 20251202T111051 | Somewhat-Bullish | Relevance: 96%
- Northwestern Mutual Wealth Management Co. increased its stake in Stryker Corporation to 54,420 shares, valued at $21.53 million, during the second quarter. The article highlights significant insider selling activity, with Director Ronda E. Stryker selling 276,173 shares for about $97.6 million. Stryker exceeded quarterly earnings expectations and received a consensus "Moderate Buy" rating from analysts with an average price target of $434.37.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-14 | Truist Securiti | $400 | $392 | +2% |
| 2025-11-14 | Wells Fargo | $456 | $452 | +1% |
| 2025-11-14 | Needham | $448 | $448 | 0% |
| 2025-11-14 | BTIG | $410 | $410 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-14 | Truist Securiti | main | Hold |
| 2025-11-14 | Wells Fargo | main | Overweight |
| 2025-11-14 | Needham | reit | Buy |
| 2025-11-14 | BTIG | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.76M) |
| Sells | 7 ($21.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (+0.8%)
- Blackrock Inc.: 7.0% (+0.4%)
- JPMORGAN CHASE & CO: 6.2% (+95.3%)
- Greenleaf Trust: 4.3% (-0.3%)
- State Street Corpora: 3.9% (-0.1%)

### Key Risks

1. Heavy insider selling: $21M sold (7 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.47 suggests fair value with growth premium. Forward P/E 24.5x stretched relative to 10% growth. Balance sheet: $1.4B free cash flow. Insider selling cluster ($21.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $135.5B |
| Beta | 0.90 |
| 52W Range | $329.16 - $406.19 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.47 |
| Forward P/E | 24.5 |
| Current P/E | 27.0 |
| YoY Growth | 10.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.8% to -1.6% (-3.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.6pp (needs >4.0% for momentum thesis). Below SMA200 (0.97x), long-term trend not supportive. MACD histogram positive (0.73), confirming momentum. RSI neutral at 48. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.56% (CS: 35) | Neutral |
| RSI_14 | 48.1 | Neutral |
| MACD Histogram | 0.73 | Bullish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 0.993x | Below |
| vs SMA200 | 0.970x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $365.95
- **Stop Loss:** $351.89 (3.8% risk)
- **Target:** $394.07 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 67
- **Position Value:** $24,518.65
- **Portfolio %:** 24.52%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-01-27 (Est: $4.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.13 | $3.19 | +1.9% |
| 2025Q2 | $3.07 | $3.13 | +1.9% |
| 2025Q1 | $2.73 | $2.84 | +4.0% |
| 2024Q4 | $3.87 | $4.01 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*